In many parts of the world, there is limited access to eye care professionals, diagnostic tools, and treatment. This lack of services prevents early detection and timely treatment of conditions that could lead to blindness or vision impairment.
AI technology remains inaccessible to many, leading to preventable blindness in treatable diseases due to the unequal distribution of advanced healthcare tools.
Many cameras capture only a limited field of view of the retina, which can result in incomplete images. Clinicians may miss important parts of the retina where ROP changes occur, leading to under-diagnosis or misdiagnosis.
Streamline the management of Retinopathy of Prematurity (ROP) exams with our intuitive software designed for collaborative care. iTelegen simplifies the scheduling process, reduces administrative burdens, and enhances patient care, allowing doctors to easily access and review diagnostic images for informed decision-making.
iTelegen+™ combines the intuitive iTelegen ROP software with the support of Artificial Intelligence (AI) to further improve the efficiency of ROP care.
Our patented Scanning Laser Ophthalmoscope (SLO) camera is designed to capture high-quality, truly ultra-wide field images of eyes across all ages.
Our advanced Optical Coherence Tomography (OCT) system is designed to capture high-resolution cross-sectional images of the retina for patients of all ages, from neonates to adults.
Our team began by addressing retinopathy of prematurity (ROP), the leading cause of childhood blindness. We developed innovative technology to prevent blindness in premature babies and partnered with Orbis International to scale this solution globally. In solving this critical problem, we created a line of comprehensive products that extend beyond ROP, offering advanced eye care technology for people of all ages in all parts of the world.
There are no pediatric UWF cameras on the market
There are no portable OCTs on the market
There are no approved AI algorithms for children with eye disease
Siloam Vision was founded by ophthalmologists Dr. Pete Campbell and Dr. Paul Chan, both key members of the iROP consortium, a pioneering imaging and informatics research team that has been advancing solutions for retinopathy of prematurity (ROP) since 2010. Our focus at Siloam Vision is pioneering an eye care technology company dedicated to preventing blindness and improving visual health worldwide. With innovative solutions, and a focus on global accessibility, we are transforming the future of eye care for people of all ages.
Preventing blindness and improving the health of populations worldwide.
